Deep Track Capital, LP Viridian Therapeutics, Inc.\De Transaction History
Deep Track Capital, LP
- $2.27 Billion
- Q4 2024
A detailed history of Deep Track Capital, LP transactions in Viridian Therapeutics, Inc.\De stock. As of the latest transaction made, Deep Track Capital, LP holds 4,522,741 shares of VRDN stock, worth $66.6 Million. This represents 3.82% of its overall portfolio holdings.
Number of Shares
4,522,741
Previous 3,750,945
20.58%
Holding current value
$66.6 Million
Previous $85.3 Million
1.6%
% of portfolio
3.82%
Previous 3.15%
Shares
12 transactions
Others Institutions Holding VRDN
# of Institutions
199Shares Held
79.2MCall Options Held
477KPut Options Held
917K-
Black Rock Inc. New York, NY4.77MShares$70.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.6MShares$67.6 Million0.0% of portfolio
-
Vr Adviser, LLC New York, NY3.88MShares$57.2 Million12.28% of portfolio
-
State Street Corp Boston, MA3.52MShares$51.9 Million0.0% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA3.45MShares$50.7 Million13.28% of portfolio
About Viridian Therapeutics, Inc.\DE
- Ticker VRDN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,888,900
- Market Cap $587M
- Description
- Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye disease (TED); VRDN-002, an IGF-1R antibody, which is in Phase 1 clinical trial; and VRDN-00...